Skip to main content
Hongtao Liu, MD, Oncology, Madison, WI


Oncology Madison, WI

Hematologic Oncology

Director of stem cell transplant Associate Professor of Medicine University of Wisconsin at Madison

Dr. Liu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Liu's full profile

Already have an account?


  • Dr. Hongtao Liu is an oncologist in Madison, WI and is affiliated with University of Wisconsin-Madison. He received his medical degree from Beijing Medical University and has been in practice 24 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hematopoietic stem cell transplantation.

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Texas Tech University (Amarillo)
    Texas Tech University (Amarillo)Residency, Internal Medicine, 2005 - 2008
  • Beijing Medical University
    Beijing Medical UniversityClass of 1993

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2007 - 2026
  • WI State Medical License
    WI State Medical License 2023 - 2023
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations



  • Outcomes of IDH-Mutated Advanced Phase Ph-Negative Myeloproliferative Neoplasms Treated with IDH Inhibitors
    Hongtao Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDS
    Hongtao Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • The Immunotherapy Revolution
    The Immunotherapy RevolutionMay 3rd, 2017